BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25056394)

  • 1. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritized current unmet needs for antibacterial therapies.
    Spellberg B; Shlaes D
    Clin Pharmacol Ther; 2014 Aug; 96(2):151-3. PubMed ID: 25056396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance.
    Huque MF; Valappil T; Soon GG
    Stat Med; 2014 Nov; 33(25):4321-36. PubMed ID: 24957660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of antimicrobial resistance: new regulatory tools to support product development.
    Tomayko JF; Rex JH; Tenero DM; Goldberger M; Eisenstein BI
    Clin Pharmacol Ther; 2014 Aug; 96(2):166-8. PubMed ID: 24823890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on antibacterial and antifungal drugs - can we master the resistance crisis?
    Theuretzbacher U; Mouton JW
    Curr Opin Pharmacol; 2011 Oct; 11(5):429-32. PubMed ID: 21903474
    [No Abstract]   [Full Text] [Related]  

  • 7. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 9. Current challenges in the discovery of novel antibacterials from microbial natural products.
    Genilloud O
    Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):189-204. PubMed ID: 22963258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 12. Old and new targets of antibacterial therapy.
    Dbaibo GS
    J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pharmacodynamic research in the assessment and development of new antibacterial drugs.
    Lister PD
    Biochem Pharmacol; 2006 Mar; 71(7):1057-65. PubMed ID: 16316633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 16. Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials.
    Karpiuk I; Tyski S
    Przegl Epidemiol; 2015; 69(4):723-9, 865-70. PubMed ID: 27139351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future challenges facing the development of new antimicrobial drugs.
    Coates A; Hu Y; Bax R; Page C
    Nat Rev Drug Discov; 2002 Nov; 1(11):895-910. PubMed ID: 12415249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.